Data / Form D filings / PHOENIX BIOTECHNOLOGY INC
PHOENIX BIOTECHNOLOGY INC: Form D filings
PHOENIX BIOTECHNOLOGY INC, a biotechnology company in San Antonio, TX, filed 10 Form D notices with the SEC between 2010 and 2020. The latest, on August 17, 2020, reports $5 million sold of a $5 million offering to 1 investor.
Find out what PHOENIX BIOTECHNOLOGY INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8626 TESORO DR, SUITE 801, San Antonio, TX, 78217
- Phone
- (210) 828-4373
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Texas
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1278815
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 17, 2020 | New notice | $5,000,000 | $5,000,000 | $0 | 1 | Aug 7, 2020 | sec.gov |
| Oct 16, 2019 | Amendment | Indefinite | $1,760,700 | Indefinite | 25 | Jul 18, 2018 | sec.gov |
| Jan 9, 2019 | Amendment | Indefinite | $1,045,200 | Indefinite | 19 | Jul 18, 2018 | sec.gov |
| Oct 18, 2018 | New notice | Indefinite | $879,000 | Indefinite | 12 | Jul 18, 2018 | sec.gov |
| Jun 18, 2014 | New notice | $2,000,000 | $852,000 | $1,148,000 | 23 | Mar 19, 2014 | sec.gov |
| Dec 29, 2010 | Amendment | $3,600,000 | $3,300,664 | $299,336 | 65 | Aug 17, 2010 | sec.gov |
| Nov 4, 2010 | Amendment | $3,600,000 | $3,196,664 | $403,336 | 62 | Aug 17, 2010 | sec.gov |
| Oct 7, 2010 | Amendment | $3,600,000 | $2,708,264 | $891,736 | 54 | Aug 17, 2010 | sec.gov |
| Sep 10, 2010 | Amendment | $3,600,000 | $1,120,600 | $2,479,400 | 30 | Aug 17, 2010 | sec.gov |
| Aug 30, 2010 | New notice | $401,600 | $401,600 | $0 | 11 | Aug 17, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Crandell Addington | Executive Officer, Director | |
| Jeffrey S. Thompson | Director | |
| Andrew J. Butler | Director | |
| Macdonald T. Haskell | Director | |
| Andrew J. Whitney | Director | |
| Lou T. Kost | Executive Officer, Director | |
| Robert A. Newman | Executive Officer, Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Aug 17, 2020 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PHOENIX BIOTECHNOLOGY INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.